Y-mAbs Therapeutics Inc (YMAB)
8.28
-0.29
(-3.38%)
USD |
NASDAQ |
Dec 20, 16:00
8.31
+0.03
(+0.36%)
After-Hours: 20:00
Y-mAbs Therapeutics Profit Margin (Quarterly): -37.91% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.45% |
| Return on Assets | -18.50% |
| Return on Invested Capital | -24.45% |
| Gross Profit Margin (Quarterly) | 87.82% |
| Operating Margin (Quarterly) | -46.41% |
| Return on Net Operating Assets | -66.74% |